A multi-centre, open, investigator initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0.015% on the face and scalp, and 0.05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT) - Y. C. Kim, J. Y. Yang, J. S. Yoon, S. J. Jo, H. H. Ahn, K.-H. Song, D.-Y. Lee, K.-Y. Chung, Y.-H. Won, I.-H. Kim (Wiley-Blackwell, 2018)
6143564